Search
for
Sort by
Research 631–660 of 1000+
- Phyllanthus emblica L.
- The role of exosomes in follicle regeneration of androgenic alopecia
- Male Pattern Baldness – Symptoms, Causes, and Treatments
- LLLT: Does It Work?
- Preclinical and Clinical Development of a Penetration Enhancer SEPA 0009
- Minoxidil
- Biomimetic Cell Membrane‐Coated Scaffolds for Enhanced Tissue Regeneration
- Miscellaneous Skin Diseases
- Eyelashes: Anatomical and Physiological Features, Eyelash Loss and Trichomegaly: Review
- ALOPECIA AS A CONSEQUENCE OF TACROLIMUS THERAPY IN RENAL TRANSPLANTATION?
- ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients
- Alopecia areata in a renal transplant recipient on cyclosporin
- The Evaluation and Management of Hirsutism
- ANDROGENETIC ALOPECIA: FROM MOLECULAR MECHANISMS TO ADVANCED TOPICAL DELIVERY SYSTEMS WITH EMPHASIS ON POLYMERIC MICELLES
- Estudo da capacidade de crescimento capilar de produtos derivados do alecrim (Rosmarinus offici-nalis) em camundongos (Mus musculus) C57BL6//BIOU
- 医療機関における男性型脱毛症（AGA）診療に対する受診満足度調査
- Targeting to the hair follicles: Current status and potential
- An Overview of the Biology of Platelet-Rich Plasma and Microneedling as Potential Treatments for Alopecia Areata
- Principles of management of women with hirsutism – a dermatologist’s perspective
- Madarosis: A marker of many Maladies
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Endocrinology Update: Hirsutism.
- Herbal Hair Gel Formulation having 5α-Reductase Inhibitory Activity and its Standardization by HPTLC
- A New Era of 5α-Reductase Inhibitors for Androgenetic Alopecia
- Hipertricose generalizada exuberante em um lactente: relato de caso
- Chemically Induced Hair Loss/Alopecia
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Cutaneous Toxicities From Transplantation-Related Medications
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia